ezetimibe has been researched along with Dementia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aeschbacher-Germann, M; Aujesky, D; Bauer, DC; Blum, MR; Del Giovane, C; Gencer, B; Kaiser, N; Moutzouri, E; Rodondi, N; Speierer, A | 1 |
| Dearborn-Tomazos, JL; Giugliano, RP; Goldstein, LB; Hirsh, BJ; Peña, JM; Selim, MH; Toth, PP; Woo, D | 1 |
| Azarpazhooh, MR; Bogiatzi, C; Hankey, GJ; Larsson, SC; Spence, JD | 1 |
3 review(s) available for ezetimibe and Dementia
| Article | Year |
|---|---|
Lipid-Lowering Trials Are Not Representative of Patients Managed in Clinical Practice: A Systematic Review and Meta-Analysis of Exclusion Criteria.
Topics: Aged; Cholesterol; Dementia; Ezetimibe; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Proprotein Convertase 9 | 2023 |
Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association.
Topics: American Heart Association; Anticholesteremic Agents; Brain; Cholesterol, LDL; Dementia; Ezetimibe; Hemorrhagic Stroke; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Prospective Studies; Retrospective Studies; Stroke | 2023 |
Stroke Prevention in Older Adults: Recent Advances.
Topics: Aged; Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Atrial Fibrillation; Carotid Stenosis; Dementia; Diet; Diet, Vegetarian; Endarterectomy, Carotid; Ezetimibe; Factor Xa Inhibitors; Gastrointestinal Microbiome; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Patient Care Planning; Patient Selection; Platelet Aggregation Inhibitors; Renal Insufficiency; Stents; Stroke; Vascular Stiffness; Vitamin B Complex | 2020 |